Efficacy and safety of saxagliptin in combination with metformin as initial therapy in Chinese patients with type 2 diabetes: Results from the START study, a multicentre, randomized, double-blind, active-controlled, phase 3 trial

Dou, JT; Ma, JH; Liu, J; Wang, CJ; Johnsson, E; Yao, H; Zhao, J; Pan, CY

Pan, CY (reprint author), Gen Hosp Peoples Liberat Army, Dept Endocrinol, 28 Fuxing Rd, Beijing 100853, Peoples R China.

DIABETES OBESITY & METABOLISM, 2018; 20 (3): 590

Abstract

AimTo assess the efficacy and safety of saxagliptin plus metformin over 24weeks in pharmacotherapy-naive Chinese patients with type 2 diabetes mellitu......

Full Text Link